By leveraging our novel GWAS results to perform APOE*4 stratified cTWAS, we further identified 13 known and 29 novel AD risk loci whose associations depended on APOE*4 status and for which we could nominate potential causal cell-type-gene pairs. Here, APOE is linked to Alzheimer disease.